Market Insight - Island state looking beyond its own shores
This article was originally published in Scrip
Executive Summary
The Singaporean biomedical sciences sector punches well above its weight, accounting for more than 4% of the country's GDP. The HSA, Singapore's health products regulatory agency, sees alliances, forged both within the ASEAN region and further afield, as critical to fulfilling its mission, CEO Dr John Lim tells Ian Haydock.